Tags
- 1D00C3
- 23andMe
- 454 Life Sciences
- AAB-001
- Aastrom Biosciences
- Abbott Labs
- Abbott Labs
- Abgenix
- Abiomed
- Ablynx
- Abraxane
- Abraxis
- Abraxis Pharmaceutical
- Acadia Pharmaceuticals
- ACAM2000
- Acambis
- ACC-001
- Accelerator Corporation
- Acceleron
- Accupril
- Aclasta
- acomplia
- Acorda Therapeutics
- ACP-104
- ACP-106
- actavis
- Actelion
- Actemra
- Actos
- Acura Pharmaceuticals
- ACX10061
- AD 337
- Adams Respiratory
- AdcockIngram
- Adderall
- Addex
- Addex Pharmaceuticals
- Adenosine Therapeutics
- ADH-1
- ADHD
- ADHD patch
- Adherex
- adjuvant
- Adnexus Therapeutics
- Adolor
- Advagraf
- Advair
- Advanced Cell Technology
- Advanced Life Sciences
- Advancis Pharmaceutical
- AdvanDx
- ADVENTRX Pharmaceuticals
- adverse events
- Advexin
- AeroLEF
- AEterna Zentaris
- AEZS-108
- Affymax
- affymetrix
- Aflibercept
- age related macular degeneration
- Agendia
- Agensys
- AGI-1067
- Agile Therapeutics
- Aging
- Agios Pharmaceuticals
- Agreement
- Agros Therapeutics
- Aidan King
- Aileron Therapeutics
- AkaRx
- Akorn
- AKR-501
- Akzo Nobel
- Alan Frazier
- Alan Levin
- Alan Trounson
- Albuferon
- Alcon
- Aldagen
- Alder Biopharmaceuticals
- Alessandro Banchi
- Alex Gorsky
- Alexander Fleming
- Alexion
- Alexion Pharmaceuticals
- Alexza
- Alexza Pharmaceuticals
- Alfacell
- Alimera Sciences
- Alkermes
- Allergan
- almorexant
- Alnylam
- alpharma
- ALS-357
- Altabax
- altana
- Altus Pharmaceuticals
- alvimopan
- Alzheimer's
- Alzhemed
- Amarin
- AmbioPharm
- Ambit Biosciences
- Ambrilia Biopharma
- Ambrx
- American Medical Association
- AmerisourceBergen
- Amgen
- Amicus Therapeutics
- Amoxicillin
- Amulet Pharmaceuticals
- Amylin pharmaceuticals
- Amyris Biotechnologies
- ANA975
- anacetrapib
- Anacor
- Anacor Pharmaceuticals
- Anadys Pharmaceuticals
- analysts
- Anaphore
- Anaptys Biosciences
- Andreas Struengmann
- Andrew von Eschenbach
- Andrew Witty
- Andrin Oswald
- Andrx
- Anemia drugs
- Anesiva
- Angiocept
- Angiotech
- Angiotensin
- Anika Therapeutics
- Anormed
- Anthera
- anthrax
- anthrax vaccine
- anti-counterfeiting
- Anti-TNF
- antibiotic
- antibiotics
- antibodies
- antibody
- Antibody technology
- antidepressant
- antigen
- Antigenics
- antisense
- Antisense Pharma
- Antisoma
- antithrombotic theory
- antiviral drug
- APD125
- Apitope Technology
- apixaban
- Apogenix
- Applied Biosystems
- Approvable letter
- APT Pharmaceuticals
- Aptuit
- Arana Therapeutics
- Aranesp
- Archemix
- Arcion Therapeutics
- Ardana
- Ardea BioSciences
- Arena Pharmaceuticals
- arGentis
- Argos Therapeutics
- Ariad Pharmaceuticals
- Arius
- Arizona
- Ark Therapeutics
- Arlene Chiu
- Arnold Schwarzenegger
- Array BioPharma
- Arrow International Limited
- ART104
- arthritis
- Arthur Levinson
- Aryx Therapeutics
- AS1404
- ASA404
- Ascendis Pharma
- ASCO
- Asenapine
- Asentar
- Asia
- Aspen Technology
- Asphelia Pharmaceuticals
- Aspreva
- Aspreva Pharmaceuticals
- assets
- Astellas
- Astellas Pharma
- Astex
- Astex Therapeutics
- asthma
- AstraZeneca
- Asuragen
- Athenagen
- Atherogenics
- Atherosclerosis
- atiplatelets
- Atlas Venture
- Atria
- atrial fibrillation
- ATryn
- Auriga Laboratories
- Auspex Pharmaceuticals
- Australia
- autoimmune disease
- Auxilium Pharmaceuticals
- Avalon Pharmaceuticals
- Avandia
- Avanir Pharmaceuticals
- Avant Immunotherapeutics
- Avantome
- Avastin
- Avelox
- Aveo
- AVEO Pharmaceuticals
- Averion
- Avian Flu
- Avian flu pandemic
- Avian flu vaccine
- avian flu virus
- AVN316
- AVN994
- Axcan Pharma
- AZ-002
- AZ-004
- Azilect
- BA058
- Balsalazide
- Baltimore
- bapineuzumab
- Baraclude
- Barr Pharmaceuticals
- Barrier Therapeutics
- Basilea
- Bausch & Lomb
- Baxter
- Baxter International
- Bayer Healthcare
- Bayer Schering
- Bazedoxifene
- BCI-540
- BDSI
- Belgium
- belinostat
- Bellco Health
- benign prostatic hyperplasia
- Bentley Pharmaceuticals
- Berkely HeartLab
- Bernard Poussot
- Betagenon
- Betaseron
- BG Medicine
- Bidil
- Big Pharma
- Bill and Melinda Gates Foundation
- Bill Wells
- Billionaire
- BIND Biosciences
- BIO 2008
- Bioalliance Pharma
- Biocon
- Biocryst
- biodefense
- BioDelivery Sciences
- BioDuro
- Bioenvision
- BioFocus DPI
- Biogen Idec
- Biogenerics
- BioInvent
- Biologics
- BioMarin Pharmaceutical
- biomarkers
- Biomira
- BioMS Medical
- Bioniche Life Sciences
- Bionomics
- biopharmaceutical company
- BioProcessors
- biopure
- BioSante
- biosimilar
- biosimilars
- BioSynthema
- Biota
- biotech
- Biotech company news
- biotech drugs
- biotech growth
- biotech investing
- Biotech investor
- Biotech IPO
- Biotech IPO
- biotech jobs
- biotech news
- biotech patent news
- biotech revolution
- Biotech Stock
- biotech stocks
- Biotech Venture Capital
- biotechnology
- biotechnology company
- Biotest
- Biovail
- BioVex
- Biovitrum
- Bipolar
- birth control
- BLA
- Black Box Warning
- Bladder Cancer
- blinatumomab
- blockbusters
- blood cancer
- blood clots
- blood pressure
- blood substitute
- boceprevir
- Boda
- Boehringer Ingelheim
- Boehringer Ingelheim; Actimis
- bone cancer
- Boston
- Boston Scientific
- Botox
- Bradley Pharma
- brain cancer
- brain disease
- BrainCells
- breast cancer
- Bremelanotide
- Brent Norton
- Bridion
- Briggs Morrison
- Bristol-Myers Squibb
- Brostallicin
- Bryan Lawis
- Bryan Morton
- Bush Administration
- business development
- Busulfex
- buyout
- buyouts
- Byetta
- California
- Callisto Medical
- Cambria Biosciences
- Cambria Pharmaceuticals
- cambridge antibody technology
- cambridge massachusetts
- Campath
- Canada
- Cancer
- cancer drug
- Cancer Drugs
- cancer pain
- cancer research
- Cancer Therapeutics CRC
- cancer therapies
- cancer vaccine
- Cancidas
- Cangene
- capital partners
- Cara Therapeutics
- Caraco Pharmaceutical Laboratories
- Cardene
- Cardiology
- Cardiome
- Cardiome Pharma
- cardiovascular risks
- Carl Icahn
- Carlo Paribello
- Carrolee Barlow
- case studies
- Catalyst Pharmaceutical
- CD103
- CDC
- CDX-110
- ceftobiprole
- Celacade
- Celator Pharmaceuticals
- Celebrex
- Celera
- Celgene
- Cell Genesys
- Cell Therapeutics
- CellCept
- CellCyte
- Celldex
- Celldex Therapeutics
- Cellerix
- cells
- Cellular Dynamics
- Cellzome
- Celtic Pharma
- Celtic Pharmaceutical
- Centocor
- central nervous system
- CEO
- CEO pay
- Cephalon
- Ceplene
- Ception Therapeutics
- Ceragenix
- Cerepro
- Ceres
- Cervarix
- cervical cancer
- cervical cancer vaccine
- CETP inhibitors
- Cetrorelix
- CFO
- Chandrix
- Charles Baum
- Charles Butt
- Charles Grassley
- Chelsea Therapeutics
- ChemGenex
- Chemokine Therapeutics
- chemotherapy
- chief medical officer
- chief operating officer
- chief scientific officer
- China
- Chinese Academy of Merical Sciences
- Chiron
- Chmp
- cholesterol
- cholesterol drug
- Chris Brinsmead
- Chris Newton
- Christy Shaffer
- Chronic Idiopathic Constipation
- chronic lymphocytic leukemia
- Chugai
- Cialis
- Cimzia
- Cinryze
- CK-1827452
- Claratin
- Claritin
- Clarus Ventures
- Class Action
- Cleveland Clinic
- Cleviprex
- Clinical Data
- Clinical Development
- Clinical trial news
- Clinical Trial Results
- Clinical Trials
- ClinPhone
- cloning
- CNTO 1275
- Codexis
- Cofactor
- Cogentus Pharmaceuticals
- Col-118
- Colazal
- collaborations
- CollaGenex
- CollaGenex Pharmaceuticals
- CollaRx
- colon cancer
- Colorado
- colorectal cancer
- CoLucid
- CoLucid Pharmaceuticals
- combination
- combinatorx
- combined company
- combo drug
- CoMentis
- commercialization
- competitors
- Compugen
- Computer Model
- Concert Pharmaceutcals
- Concert Pharmaceuticals
- Congress
- Constellation Pharma
- Constellation Pharmaceuticals
- contraceptive
- controversy
- Copaxone
- COPD
- CORDAPTIVE
- Coreg
- Corey Goodman
- Corgentech
- corifollitropin alfa
- Cork
- Cornerstone BioPharma
- Cortex Pharmaceutcials
- Corthera
- Cougar Biotechnology
- counterfeit drugs
- Covance
- Covidien
- cox 2 inhibitor
- cox 2 inhibitors
- CPX-351
- CR014
- Craig Tooman
- Crestor
- Critial Path Initiative
- critical therapeutics
- critics
- CRO
- Crohn's disease
- Crucell
- CSL
- CTEP inhibitors
- CU-2010
- Cubicin
- Cubist Pharmaceuticals
- Curacyte
- curagen
- Curt Selquist
- CV Therapeutics
- CX717
- cybrids
- Cymbalta
- Cyntellect
- Cypress
- cystic fibrosis
- CytImmune Sciences
- Cytochroma
- CytoFab
- Cytogen
- CytoGenix
- cytokinetics
- Cytos
- Cytos Biotechnology
- CytRx
- d center
- Dacogen
- Daiichi Sankyo
- Daniel Adams
- Daniel S. Goldberg
- Daniel Vasella
- Daniel Zurr
- dapagliflozin
- DARA BioSciences
- darmstadt germany
- data monitoring committee
- Dave Holveck
- David Baltimore
- David Brennan
- David Eveleth
- David Heimbrook
- David Holveck
- David J. Mazzo
- David Mazzo
- David Mott
- David Murdock
- deal
- Deals
- Deals
- Deciphera Pharmaceuticals
- Decode Genetics
- Delcath
- Democrats
- Dendreon
- Denmark
- Denosumab
- Denosumab. goliumumab
- Denosumab. golumumab
- Denver
- Department of Defense
- Department of Health and Human Services
- DepoDur
- Depomed
- depression
- Desmoteplase
- Deval Patrick
- development costs
- development pact
- development therapies
- DIA
- Diabetes
- Diakron Pharmaceuticals
- Diangostics
- Dicerna Pharmaceuticals
- Difluprednate
- Dimebon
- Dimera
- Diractin
- Direvo
- Direvo Biotech
- dirucotide
- Discovery Labs
- doctors
- dopamine
- Dor BioPharma
- Doribax
- Douglas Squires
- Dov Pharmaceutical
- DPP-4 inhibitors. diabetes
- Dr. Reddy
- Dr. Reddy's
- Draper Laborator
- Drew Faust
- Droxidopa
- Drug approvals
- drug candidates
- drug combination
- drug delivery technologies
- drug delivery technology
- drug developer
- Drug Development
- Drug Discovery
- drug marketing
- drug prices
- Drug repositioning
- drug reprofiling
- Drug Resistance
- Drug Safety
- Drug Trials
- Drug-Induced Human Liver Injury
- DTC advertising
- Duska Therapeutics
- DX-88
- Dyadic
- Dyax
- Dynavax
- Dynavax Technologies
- Ebola Hemorrhagic Fever
- Economic development
- eculizumab
- efavirenx
- Egg-based
- Eisai
- EKR Therapeutics
- Elan
- Elan Drug Technologies
- Eli Lilly
- Elixir Pharmaceuticals
- Ellen McDonald
- elotuzumab
- Elusys Therapeutics
- Embeda
- embryonic stem cell
- embryonic stem cells
- EMEA
- EMEA Approval
- Emergent BioSolutions
- Emerging
- Emerging Drug Developer
- Emerging Drug Developer. Paul Rubin
- emerging markets
- emerging outsourcing trends
- EmergingMed
- Emisphere
- En Li
- Encysive
- Endo Parmaceuticals
- Endocrinaology
- Enlight Biosciences
- Enobia
- Enobia Pharma
- Entelos
- Entereg
- EntreMed
- Entrepreneur
- Entrepreneur. venture capital
- Enzon Pharmaceuticals
- EpiCeram
- Epix
- EPIX Pharmaceuticals
- equity investment
- Erbitux
- erectile dysfunction
- Erythema
- Erythropoietin
- ESBATech
- Esperion
- Esperion Therapeutics
- Esprit
- Esprit Pharma
- Eugene Melnyk
- Europe
- European Commission
- EUSA Pharma
- EvaMist
- Evista
- Evotec
- EVT 201
- EXACT Sciences
- Excalibur
- Executives
- Exelixis
- Exeter Life Sciences
- Experimental Drugs
- experimental therapy
- Extends Survival
- Exubera
- Eyegate
- Eyetech
- f-star
- factive
- fake pharmaceuticals
- Famvir
- Fast Track
- Fast Track designation
- Fate Therapeutics
- Fauci
- Favrille
- FDA
- FDA approval
- FDA approval & regulation
- FDA regulation
- FDA rejection
- FDA update
- FDA update
- FDA warning
- federal judge
- female sexual dysfunction
- Fentora
- FermaVir
- fertility
- Fibromyalgia
- Fierce 15
- finasteride
- Flamel
- Flemming Lindeløv
- Florida
- flu
- flu vaccine
- flu vaccines
- FluBlok
- Flumist
- Flurizan
- Flutiform
- FMD Report
- Follica
- foot-and-mouth
- Forbes Medi-Tech
- Forest Lboratories
- Formac Pharmaceuticals
- fospropofol disodium
- Fountain Healthcare Partners
- Fovea
- Fovea Pharmaceuticals
- Fragile X Research
- Frank Baldino
- Franz Humer
- Fred Eshelman
- Fred Hassan
- Frova
- ftc
- funding
- funding gap
- FV-100
- Gabapentin GR
- Galantamine Hydrobromide
- Galapagos
- Galderma
- Galenica
- galvus
- Gammagard
- Gardasil
- Garo Armen
- Garry Nicholson
- Gary Shearman
- GE
- Gedeon Richter
- gemcitabine
- Gemin X Pharmaceuticals
- Gen-Probe
- Genaera
- Genasense
- Gene Logic
- gene targeting
- gene therapy
- GeneNews
- Genentech
- general counsel
- General Electric
- Generic
- Generic Biologics
- Generics
- genes
- GeneThera
- genetic model
- genetic test
- Genetically Engineered Animals
- genetics
- GENFIT
- Genitope
- Genizon
- GenMab
- Genocea Biosciences
- Genome
- Genomic Vision
- Genomics
- Genta
- Gentium
- Genvec
- Genzyme
- George Church
- Geron
- gifts
- Gilead
- Gilead Sciences
- glaucoma
- GlaxoSmithKline
- Gleevec
- Glenmark Pharmaceuticals
- Glenn Gormley
- globalization
- GlobeImmune
- GlycArt
- Glyn Edwards
- Goldmans Sachs
- Golimumab
- goliumumab
- Golmumab
- Gordon Wier
- GPC
- GPC Biotech
- Grassley
- green initiatives
- Gregory Lucier
- Grupo Ferrer
- GTC Biotherapeutics
- GTC Therapeutics
- GTx
- GVAX
- GVAX immunotherapy
- GW Pharma
- GWAS
- Gwen Krivi
- H. Lundbeck
- HAART
- HAE
- Halozyme
- Hana Biosciences
- Haptogen
- Harvard
- Harvard Medical School
- Hawaii Biotech
- HBM Bioventures
- HE3235
- head and neck cancer
- Head Lice
- Health Canada
- HealthLinx
- heart disease
- heart drug
- Hemo-Stream
- hemophilia
- Hemopure
- Henri Termeer
- Henry E. Blair
- hepatitis B
- Hepatitis C
- Heplisav
- Herceptin
- hereditary angieoedema
- Heritage Pharmaceuticals
- Hesperion
- High Throughput Genomics
- HIPAA
- Hirofumi Onosaka
- HIV/AIDS
- HIV/AIDS
- HIV/AIDS
- HIV/HBV
- Hollis Eden
- Hollis-Eden
- hostile takeover
- Howard Richman
- Hubert Birner
- Human African Tryanosomiasis
- Human Genome Sciences
- human growth hormone
- Humana
- HuMax CD-20
- HuMax-EGFr
- Humira
- Huntington's
- HVC-796
- hybrid
- Hycamtin
- Hydra Biosciences
- Hyperion Therapeutics
- hypertension
- iBioPharma
- Ibis Biosciences
- Ibraheem Mahmood
- iCardiac Technologies
- Iconix Biosciences
- IDEA
- Idenix Pharmaceuticals
- Idera
- IDM Pharma
- Ikonisys
- Illumina
- iloperidone
- ImaRx
- ImaRX Therapeutics
- IMC-11F8
- IMC-A12
- ImClone
- Immtech
- Immtech Pharmaceuticals
- Immune Design
- immune response
- immune system
- ImmunoGen
- Immunosyn
- immununotherapy
- IMS Health
- Indai
- Indevus
- India
- indication
- Indonesia
- Inex Pharmaceuticals
- infectious disease
- infectious diseases
- Infinity Pharmaceuticals
- inflammatory conditions
- inflammatory diseases
- injectable
- Innocoll
- Innogenetics
- Innovative Medicines Initiative
- INNOVIVE Pharmaceuticals
- INO-4885
- INO-8875
- Inotek
- Inotek Pharmaceuticals
- Inovio
- Insmed
- insomnia
- Inspire Pharmaceuticals
- insulin
- insurance companies
- Intas
- Integrated Biopharma
- Intercell
- Intermune
- InterWest Partners
- Introgen Therapeutics
- investigation
- investigators
- investment
- investments
- Investor
- Invitrogen
- Invus
- IoGen
- Iomai
- IP
- IPI-504
- ipilimumab
- IPSC
- Ipsen
- Ireland
- Irritable Bowel Syndrome
- Isconova
- Isentress
- Isis
- ISIS 301012
- ISIS 388626
- Isis Pharmaceuticals
- Isolagen
- Isotechnika
- Israel
- ISTA Pharmaceuticls
- Itero
- Itero Biopharmaceuticals
- IXEMPRA
- J. Craig Venter
- J. Michael Pearson
- Jack Lief
- James Bianco
- James Cornelius
- James Mullen
- James S. Kuo
- James Shannon
- James White
- Janssen
- Januvia
- Japan
- Jassen Galapagos
- Javelin Pharmaceuticals
- Javier San Martin
- Jazz Pharmaceuticals
- JDS Pharmaceuticals
- Jean-Luc Belingard
- Jean-Pierre Garnier
- Jeffrey H. Buchalter
- Jeffrey Kindler
- Jeol Lexchin
- Jerini
- Jim Kerstetter
- job cuts
- Joe Bolen
- John C. Martin
- John Dyer
- John Johnson
- John Knopf
- John LaForge
- John LaMattina
- John Lechleiter
- John Milligan
- John Oyler
- John P. Longenecker
- John P. Walker
- Johnson & Johnson
- Jolee Mohr
- Jon P. Stonehouse
- Joseph Yanchik
- Journal of the American Medical Association
- Juergen Ernst
- Justiva
- Juvaris BioTherapeutics
- JZP-4
- JZP-7
- KAI Pharmaceuticals
- KAI-9803
- Karo Bio
- KB2115
- Keith Leonard
- Keryx Biopharmaceuticals
- Ketek
- Kevin Sharer
- Kiadis Pharma
- kidney cancer
- kidney disease
- kinase
- King Pharmaceuticals
- Kingsbridge Capital
- Kirsten Drejer
- Kleanthis Xanthopoulos
- Kleiner Perkins Caufield & Byers
- Knome
- Kohl
- Konrad Hochedlinger
- Kos Parmaceuticals
- KRX-0401
- KV Pharmaceutical
- Kynapid
- Kyowa Hakko
- Kyphon
- Kythera Biopharmaceuticals
- L. Patrick Gage
- Labopharm
- Lacosamide
- Lance Ignon. James P. Panek
- Langdon Miller
- Larry Goldstein
- Lawrence Bloch
- Lawrence Tamarkin
- lawsuits
- layoff
- layoffs
- LEAD Therapeutics
- legislation
- Leslie Browne
- Letairis
- leukemia
- Lev
- Lev Pharmaceuticals
- Levaquin
- Levemir
- Levitra
- Lexapro
- Lexicon
- Lexiscan
- Licensing deals
- Ligand
- Ligand Pharmaceuticals
- Light Sciences Oncology
- LigoCyte
- LigoCyte Pharmaceuticals
- Linaclotide
- LineaGen
- Lipid Sciences
- Lipitor
- Liraglutide
- Lithium QD
- Liver
- Living Cell Technologies
- Lobbying
- Longevity
- lorcaserin
- Lovenox
- LSP
- Lu AA21004
- Lucentis
- Lundbeck
- lung cancer
- lupus
- Lupus Nephritis
- LXR-623
- LY156735
- LY2140023
- lymphoma
- MacroGenics
- MacroGenitcs
- Macugen
- macular degeneration
- major market trends
- Malvinder Mohan Singh
- MammaPrint
- Mannkind
- manufacturing
- Map Pharmaceuticals
- Marburg Fever
- Mario Capecchi
- Mark Heesen
- Mark J. Fitzpatrick
- Mark Levin
- Mark McDade
- market access strategies
- Martin Evans
- Martin Mackay
- Martin Madaus
- Martin Mattingly
- Martin O'Malley
- Martin Simonetti
- Maryland
- Massachusetts
- Massachusetts Biotechnology Council
- Matt Winkler
- Matthew Pfeffer
- Matuzumab
- maximize
- MAXY-alpha
- Maxygen
- Mayne Pharma
- MBP8298
- McNeil
- MDRNA
- MDS
- Meda
- Medarex
- Medical device
- medical device news
- Medicare
- MediGene
- MedImmune
- MediQuest Therapeutics
- Meditrina
- Medivation
- Medtronic
- Melanoma
- MEM 3454
- Memory Pharmaceuticals
- meningitis
- Menopause
- Menvo
- Merck
- Merck KgAA
- Merck Serono
- Merger
- mergers and acquisitions
- Mergers and Acqusitions
- Mergers and Acqusitions
- Merial Animal Health
- Merlin Biosciences
- MET inhibition
- Metabasis Therapeutics
- Metabolic disorders
- Metabolon
- Metastasis
- Metastatix
- MethylGene
- MGCD0103
- MGI Pharma
- Michael Loberg
- Michelle Chang
- Michigan
- Microbia
- Micromet
- microplasmin
- microRNA
- MiddleBrook Pharmaceuticals
- mifamurtide
- Migenix
- Mike Bonney
- Mike Leavitt
- Mike Varney
- Miles White
- milestones
- Millennium Pharmaceuticals
- Millipore
- Minnesota
- minorities
- mipomersen
- Miragen Therapeutics
- Mircera
- Mirina Corporation
- miRNA
- Mirus
- Mistral Pharma
- MIT
- Mitsubishi Tanabe Pharma
- MK-0524A
- molecular diagnostics
- molecules
- Momenta Pharmaceuticals
- Moncef Slaoui
- monoclonal antibodies
- monoclonal antibody
- MorphoSys
- Morvus
- motavizumab
- motesanib
- Motivizumab
- Movetis
- Moxifloxacin
- MPM Capital
- MRSA
- MSX-122
- multiple myeloma
- multiple sclerosis
- Muscular Dystrophy
- Myasthenia Gravis
- Myelodysplastic Syndromes
- myeloma
- Mylan Laboratories
- Myogen
- Myozyme
- Myriad Genetics
- Nabi
- Nabi Piopharmaceuticals
- Nancy Wexler
- NanoBio Corp.
- Nanobodies
- Nanobody
- Nanogen
- Nanosphere
- nanotech
- nanotechnology
- naproxen
- nasal spray
- Nastech
- Nat Ricciardi
- National Institutes of Health
- natrecor
- Naturlose
- Navigenics
- NDA
- Needle Insertion
- Neil Gibson
- Nektar Iherapeutics
- Neopharm
- Nereus Pharmaceuticals
- Neumune
- Neupro
- Neuralgia
- Neuralstem
- NeurAxon
- Neurimmune
- Neuro-Hitech
- Neurochem
- neurocrine biosciences
- Neurogen
- NeurogesX
- Neuromed
- neuropathic pain
- NeuroSearch
- Neuvenge
- new bird
- new blood
- New Drug Application
- New Drugs
- New England Journal of Medicine
- New Jersey
- New Molecular Entity
- New York
- Newron
- newsday
- Nexavar
- Nexium
- NexMed
- NGX-4010
- Niacin
- NICE
- Nicholas Piramal
- Nicholas Stergis
- Nick Seay
- NiCox
- NicVAX
- Nitromed
- NixOx
- NM100060
- NME
- NME approvals
- NMED-1077
- nNOS inhibitor
- Nobel Prize
- non-Hodgkin's lymphoma
- non-small cell lung cancer
- North Carolina
- North Shore Life Sciences Accelerator
- Northfield Laboratories
- Northwest Biotherapeutics
- Northwick Park
- Novacea
- Novalar Pharmaceuticals
- Novartis
- Novavax
- Noven
- Noven Pharmaceuticals
- Novexel
- Novo Nordisk
- Novocell
- NovoSeven
- Nplate
- NPS Pharmaceuticals
- Nuon Therapeutics
- Nuren Pharmaceuticals
- Nuvelo
- Nuvion
- NVCA
- NXN-188
- Nycomed
- obesity
- obsessive-compulsive disorder
- OccuLogix
- Ocera Therapeutics
- OctoPlus
- Odanacatib
- ofatumumab
- offshore outsourcing
- OGX-011
- Oliver Smithies
- Omigard
- Omrix
- Omrix Biopharmaceuticals
- OncoGenex
- Oncology
- OncoMed Pharmaceuticals
- Oncophage
- Onyx
- Onyx Pharmaceuticals
- opbesity
- OpGen
- Opioid Analgestic
- Optherion
- optimal pricing
- Optimer
- Optimer Pharmaceuticals
- Oracea
- orBec
- Orchid Cellmark
- Orchid Chemicals
- Orexigen Therapeutics
- Orexin
- Organogenesis
- Organon
- orphan drug status
- Orphan Europe
- Orphan Status
- Ortho-McNeil
- Oscient Pharmaceuticals
- OSI Pharmaceuticals
- osiris therapeutics
- osteoarthritis
- Osteologix
- osteoporosis
- osteoprorosis
- OTC drugs
- outbreak
- ovarian cancer
- Ovation Pharmaceuticals
- Oxford BioMedica
- Oxford Bioscience Partners
- Oxford University
- OXiGENE
- Oxycontin
- p53 biomarker
- Pacific Biosciences
- Pacira Pharmaceuticals
- Paclitaxel
- pain
- Pain Therapeutics
- Pain Therapies
- painkiller
- Paion
- Palatin Technologies
- pancreatic cancer
- pandemic
- pandemic flu
- Pandemic Influenza
- Paoin
- Paratek Pharmaceuticals
- Parexel
- Parion Sciences
- Parkinson's
- PARP inhibitor
- partnership
- partnerships
- patent
- Patent news
- patent rules
- patents
- Pathway Therapeutics
- Patrick Vallance
- Paul Desjourdy
- Paul Herrling
- Paul Maeder
- Paul Rubin
- PBMs
- PDI
- PDL BioPharma
- PDL241
- PDUFA
- Pearl Therapeutics
- Peking University
- Pennsylvania
- Peplin
- peptide
- Peramivir
- Perampanel
- Percivia
- Perkinelmer
- Perlegen
- Perrigo
- personalized medicine
- Peter Fellner
- Peter Kim
- PF-03187207
- Pfizer
- Pfizer Global Research
- Phamrion
- Pharma news
- pharmaceutical companies
- pharmaceutical company
- pharmaceutical industry
- pharmaceutical outsourcing
- pharmaceuticals
- Pharmacopeia
- pharmacovigilance
- Pharmathene
- Pharmaxis
- Pharmexa
- Pharming
- Pharmion
- Pharmos
- Phase 2 Discovery
- Phase I
- Phase II
- Phase III
- Phase IV
- Phenomix Corporation
- Phoenix
- Phrma
- physicians
- PI-88
- PI3-K
- Piedmont Pharmaceuticals
- pimavanserin
- Pioneer
- pipeline
- Pipex
- Piramed
- Pirbright
- Pittsburgh Life Sciences Greenhouse
- PixelEXX Systems
- PL-100
- Plan B
- Plavix
- Pliva
- PML
- PN 400
- PN400
- Point Biomedical
- Point Therapeutics
- polyheme
- Polymer Technology Group
- Portola Pharmaceuticals
- Postherpetic Neuralgia
- Pozen
- PPD
- Pradaxa
- pramiconazole
- Prana
- prasugrel
- Precision Therapeutics
- preclinical
- PregLem
- PreMD
- Presidio Pharmaceuticals
- Prestwick Pharmaceuticals
- Prevacid
- Prexige
- PricewaterhouseCoopers
- pricing
- Primera Biosystems
- priority
- Pristiq
- Private Equity
- private placement
- Proaegis Biosciences
- Proaegis Biosiences
- Procter & Gamble
- product portfolio
- profits
- Progen
- Progen Pharmaceuticals
- Progenics Pharmaceuticals
- Project BioShield
- Promacta
- Promedior
- Prostate Biomarkers
- Prostate Cancer
- protein
- Protein Sciences
- proteins
- Proteome Systems
- Proteon Therapeutics
- ProteoStasis Therapeutics
- Protez Pharmaceuticals
- Protherics
- Protiva
- Protonixo
- Provectus Pharmaceuticals
- Provenge
- Provigil
- Prulifloxacin
- PS433540
- psoriasis
- PTC Therapeutics
- PTC124
- PTI-721
- PTK 0796
- public offering
- pulmonary arterial hypertension
- Pulmonary Disease
- Purdue Pharma
- PURE Bioscience
- PZ-601
- Qiagen
- QLT
- QRxPharma
- Quaker Bioventures
- Quark Pharmaceuticals
- QuatRx Pharmaceuticals
- Quest Diagnostics
- Questcor
- Quintiles
- R&D budget
- R&D spending
- R7025
- Radius
- Radius Health
- Ranbaxy
- Raptor Pharmaceutical
- Rasilez
- Raven Biotechnologies
- Raymond Warrell
- Raymond Woosley
- ReachBio
- Reagan-Udall Foundation
- Rebif
- recall
- Reclast
- Recordati
- Red Cross
- Refib
- regeneration
- regenerative medicine
- Regeneron
- Regeneron Pharmaceuticals
- Regulation
- Regulators
- regulatory affairs
- Regulus
- Regulus Therapeutics
- REIMBURSEMENT
- reimportation
- release formulation
- ReliaGene
- Reloxin
- Relypsa
- RemberTM
- Remicade
- renal cell carcinoma
- Renovis
- Renovo
- Replidyne
- Repligen
- Replydine
- Repros
- Republicans
- Resignation
- Resolvyx
- Resolvyx Pharmaceuticals
- respiratory diseases
- Response
- Restructure
- restructuring
- resveratrol
- Retaane
- Retavase
- retention bonus
- retigabine
- REVA Medical
- RGH-188
- Rheumatoid Arthritis
- rheumatology
- rhFIB
- Rhode Island
- Rhucin
- RhuDex
- Richard Garr
- Richard Jones
- Richard Selden
- Rick Winningham
- rifaximin
- Rigel
- Rigel Pharmaceuticals
- RISPERDAL
- Rituxan
- rivaroxaban
- RNAi
- Robert Coughlin
- Robert Coury
- Robert K. Coughlin
- Robert Langer
- Robert Sobol
- Roch Doliveux
- Roche
- Roger Newton
- Roger Tung
- Romiplostim
- Rosetta Genomics
- Royal DSM
- royalty payments
- Rules-Based Medicine; Venture Capital
- Russel Medford
- Russell Greig
- Russell Herndon
- Russia
- s sales
- safety data
- safety profile
- Sagent Pharmaceuticals
- sales
- sales and marketing
- Salix Pharmaceuticals
- Sam Waksal
- Samaritan
- Samaritan Pharmaceuticals
- Samuel Saks
- San Diego
- San Francisco
- san francisco chronicle
- sandoz
- Sangamo
- Sangamo BioSciences
- Sangart
- Sanofi Aventis
- Sanofi Pasteur
- Sanofi-Aventis
- Santaris
- Santaris Pharma
- SantoSolve
- Sareum
- Sars
- Sativex
- satraplatin
- Savient Pharmaceuticals
- saxagliptin
- SB-509
- sBLA
- SC4SM
- scarring
- Schering Plough
- Schering-Plough
- schizophrenia
- schizophrenia drug
- Schwarz BioSciences
- Schwarz Pharma
- Sciele Pharma
- science
- Scil Technology
- Scleroderma
- sclerosis drug
- Scotland
- Seattle
- Seattle Genetics
- seattle times
- second half
- Second Quarter
- Selzentry
- Seminar
- Sepracor
- sepsis
- Sequel
- Sequel Pharmaceuticals
- Sequella
- sequencing
- SER-3
- Serentis
- Serenx
- series c
- Sermo
- Serono
- Severin Schwan
- SGX pharmaceuticals
- Shareholder Activists
- shareholders
- Shire
- Shire Pharmaceuticals
- Sidney Taurel
- Sierra Neuropharmaceuticals
- Siga Technologies
- Sigma-Aldrich
- Silence Therapeutics
- Silenor
- Simcere
- Singapore
- Singulair
- Sir Christopher Evans
- Sirion
- Sirion Therapeutics
- Siritis Pharmaceuticals
- sirna
- Sirna Therapeutics
- Sirtris Pharmaceuticals
- skin cancer
- skin infections
- SkyePharma
- Skypharma
- Slate Pharmaceuticals
- small business
- small molecules
- Smallpox
- smoking cessation
- SNS-595
- sofinnova ventures
- Soliris
- Solvay
- Solvay Pharmaceuticals
- SOMA
- Somatuline
- Somaxon
- Sonexa Therapeutics
- Sonus Pharmaceuticals
- Sosei
- SP-6300
- Spain
- specialty drugs
- spectrum pharmaceuticals
- Speedel
- Spheramine
- Spherix
- spin-off
- Spine Wave
- spur
- SSRI
- St. Jude Medical
- STA-4783
- Stanley Erck
- Start Licensing
- start-up
- statins
- Stedivaze
- stem cell
- Stem cell research
- Stem cells
- stents
- Steve Hartig
- Steve Worland
- Steven Engle
- Steven F. Goldstone
- Steven Kriegsman
- Stiefel Laboratories
- strain
- strategy
- Strattera
- Stromedix
- Stuart Peltz
- Sucampo
- sugammadex
- Summit Corporation
- Sun Pharmaceuticals
- Sunesis
- Sunesis Pharmaceuticals
- SuperGen
- Surfaxin
- SurModics
- Susan Desmond-Hellmann
- Swedish Orphan
- Switzerland
- Symbollon
- Symphogen
- Symphony GenIsis
- Synosia Therapeutics
- Synta Pharmaceuticals
- Syntaxin
- Systems Medicine
- TAK-475
- Takeda
- Talabostat
- Talecris Biotherapeutics
- Tamibarotene
- Tamiflu
- Tanox
- taranabant
- Tarceva
- targacept
- Targanta Therapeutics
- Targeted Genetics
- Tasigna
- tasimelteon
- TauRx Therapeutics
- Taxotere
- TB-403
- TC-2696
- TC-6499
- Tekturna
- telaprevir
- Telavancin
- Tengion
- teplizumab
- Tercica
- Terry Hisey
- Terry McGuire
- tesamorelin
- tesofensine
- Tetraphase
- Tetraphase Pharmaceuticals
- Teva
- Texas
- Texas A&M
- tezampanel
- tgAAC94
- The Bill & Melinda Gates Foundation
- The Medicines Company
- Thelin
- Theratechnologies
- Theravance
- Third Point
- Third Point LLC
- Third Rock Ventures
- Third Round
- Thomas Bigger
- Thomas Finneran
- Thomas Harlan
- Thomas J. Spencer
- Thomas Struengmann
- Threshold Pharmaceuticals
- Thrombin
- thrombocytopenia
- ThromboGenics
- Thrombosis
- Tikvah Therapeutics
- Timothy C. Rodell
- TIPO-1
- Titan Pharmaceuticals
- Tocosol Paclitaxel
- TolerRx
- Tolerx
- Top 5
- Topaz Pharmaceuticals
- Topgen
- Topigen Pharmaceuticals
- Topiramate
- Topogen
- Torcetrapib
- Torisel
- TorreyPines Therapeutics
- Tracking Stocks
- Traditional medicine
- Tramadol
- Transave
- Transgenics
- Transition Therapeutics
- Transkaryotic Therapies
- TransPharma
- Tranzyme Pharma
- Trasylol
- Tredaptive
- tremelimumab
- trends
- Trevor Mundel
- Trial results
- Tribuion
- Trimel Pharmaceuticals
- Trimeris
- Trius Therapeutics
- Trizytek
- TroVax
- TRU-015
- Trubion Pharmaceuticals
- Tuberculosis
- tumors
- Tykerb
- Type 1 Diabetes
- Type 2 Diabetes
- Tysabri
- U3
- UBC Group
- UCB
- undefined
- Unigene
- United Kingdom
- United Therapeutics
- Universal vaccine
- University of Miami
- upfront payment
- US pharmaceuticals
- ustekinumab
- UTRF
- vaccine
- Vaccines
- Valeant Pharmaceuticals
- Valstar
- Valtropin
- Vanda Pharmaceuticals
- vandetanib
- Vasogen
- Vaxgen
- VaxInnate
- VC / M&A
- Vegf Trap
- velafermin
- Velcade
- Velocigene technology
- Ventana
- Ventura County
- Venture Capital
- Venture Capital fund
- Venture capital news
- Venus Remedies
- Verispan
- vernakalant
- Vernalis
- vertex
- Verus Pharmaceuticals
- VGX Pharmaceuticals
- Viagra
- Vical
- Vidaza
- Video Games
- Vilazodone
- Vion Pharmaceuticals
- VioQuest
- Vioxx
- Viragen
- Viropharma
- virus
- Vital Therapies
- Vitamin C
- Vivus
- VLST
- voclosporin
- VRX698
- Wake Forest University School Of Medicine
- Wal-Mart
- Walgreen's
- Warburg Pincus
- Warfarin
- Warner Chilcott
- Warren Levy
- Water Street Healthcare Partners
- Watson
- Watson Pharmaceuticals
- WellGen
- West Pharmaceutical
- Wex Pharmaceuticals
- Wilex
- William Wells
- Wockhardt
- Wolters Kluwer Health
- workforce
- World Health Organization
- WuXi
- Wyeth
- Xanodyne
- Xarelto
- Xcellerex
- Xeloda
- Xenazine
- Xencor
- Xenocor
- Xenome
- Xenoport
- Xience
- XL184
- XL647
- XL784
- XL880
- Xoma
- Xomaxon
- Yasuchika Hasegawa
- YM Biosciences
- Yondelis
- Yoshihiko Hatanaka
- young scientists
- Zactima
- Zambon